Effect of Clarithromycin on Nuclear Factor-κB and Transforming Growth Factor-β in Chronic Rhinosinusitis

Laryngoscope

Volumn 114, Issue 2, 2004, Pages 286-290

  Wallwork, Ben ^a,c   Coman, William ^b   Mackay Sim, Alan ^a   Cervin, Anders ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c GOLD COAST UNIVERSITY HOSPITAL   (Australia)

Author keywords

Chronic sinusitis; Macrolide; NF B; TGF

Indexed keywords

ANTIINFLAMMATORY AGENT; CLARITHROMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROLIDE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC SINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NASAL BIOPSY; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHINITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; BIOPSY; CELLS, CULTURED; CHRONIC DISEASE; CLARITHROMYCIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NASAL MUCOSA; NF-KAPPA B; PARANASAL SINUS DISEASES; SINUSITIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0842299650     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200402000-00019     Document Type: Article

References (23)

1. Nagai H, Shishido H, Yoneda, R, et al. Long-term, low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration 1991;58:145-149.
2. Shoji T, Yoshida S, Sakamoto H, et al. Anti-Inflammatory effect of roxithromycin in patients with aspirin-intolerant asthma. Clin Exp Allergy 1999;29:950-956.
3. Hashiba M, Baba S. Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol 1996;525:73-78.
4. Cervin A, Kalm O, Sandkull P, Lindberg, S. One-year. low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucociliary parameters and nasal nitric oxide. Otolaryngol Head Neck Surg 2002;126:481-489.
5. Barnes P, Karin M. Nuclear. factor-kB, a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071.
6. Miyanohara T, Ushikai M, Matsune S, et al. Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts. Laryngoscope 2000;110:126-131.
7. Desaki M, Takizawa H, Ohtoshi, T, et al Erythromycin suppresses nuclear factor kappa-B and activator protein-1 activation in human bronchial epithelial cells. Biochem Biophys Res Commun 2000;267:124-128.
8. Massague J. The transforming growth factor-B family. Ann Rev Cell Biol 1990;6:597-641.
9. Min Y, Lee C, Rhee C, et al. Increased expression of IL-4, IL-5, IFN-gamma, IL-6, IL-8 and TGF-Beta mRNAs in maxillary mucosa of patients with chronic sinusitis. Am J Rhinol 1999;13:339-343.
10. Border W, Ruoslahti E. Transforming growth factor-B in disease: the dark side of tissue repair. J Clin Invest 1992;90:1-7.
11. Coste A, Lefaucheur J, Wang Q, et al. Expression of the transforming growth factor B isoforms in inflammatory cells of nasal polyps. Arch Otolaryngol Head Neck Surg 1998;124:1361-1366.
12. Postlethwaite A, Keski-Oja J, Moses HL, et al, Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor-beta. J Exp Med 1987;165:251-256.
13. Border R, Noble NA. Transforming growth factor-B in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
14. Sassa K, Mizushima Y, Kobayashi M. Differential modulatory effects of clarithromycin on the production of cytokines by a tumour. Antimicrob Agents Chemother 1999;43:2787-2789.
15. Li Y, Wang H. The effect of erythromycin on NF-kappaB activation and cytokines mRNA expression in bleomycin-induced pulmonary fibrosis in rats [Abstract]. Zhonghua Jie He He Hu Xi Za Zhi 1999;22:725-727.
16. Baeuerle P, Henkel T. Function and activation of NF-kappaB in the immune system. Ann Rev Immunol 1994;12:141-179.
17. Manning A, Anderson DC. Transcription factor NF-kB, an emerging regulator of inflammation. Ann Rep Med Chem 1994;29:235-244.
18. Gosset P, Tillie-Leblond I, Janin A, et al. Expression of E-selectin, ICAM-1 and VCAM-1 on bronchial biopsies from allergic and non-allergic asthmatic patients. Int Arch Allergy Immunol 1995;106:69-77.
19. Wallwork B, Coman W, Feron F, et al. Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis. Laryngoscope 2002;112:1827-1830.
20. Matsuoka N, Eguchi K, Kawakami A, et al. Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells. Clin Exp Immunol 1996;104:501-508.
21. Inamura K, Ohta N, Fukase S, et al. The effect of erythromycin on human peripheral neutrophil apoptosis. Rhinology 2000;38:124-129.
22. Hand W, Hand D, King-Thompson N. Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1990;34863-70.
23. Hardy D, Guay D, Jones R. Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological and clinical overview. Diagn Microbiol Infect Dis 1992;15:39-53.